4/A

MAIN DOCUMENT DESCRIPTION

Company: REGENERON PHARMACEUTICALS, INC.
Filed: October 18, 2006
Period of Report: September 13, 2006
Accession Number: 0001209191-06-055148

View Document ↗ View on SEC.gov ↗